The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment V Krajka-Kuźniak, J Paluszczak, W Baer-Dubowska Pharmacological reports 69 (3), 393-402, 2017 | 284 | 2017 |
The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells J Paluszczak, V Krajka-Kuźniak, W Baer-Dubowska Toxicology letters 192 (2), 119-125, 2010 | 260 | 2010 |
Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines V Krajka-Kuźniak, J Paluszczak, H Szaefer, W Baer-Dubowska British Journal of Nutrition 110 (12), 2138-2149, 2013 | 149 | 2013 |
Pterostilbene is equally potent as resveratrol in inhibiting 12‐O‐tetradecanoylphorbol‐13‐acetate activated NFκB, AP‐1, COX‐2, and iNOS in mouse epidermis M Cichocki, J Paluszczak, H Szaefer, A Piechowiak, AM Rimando, ... Molecular nutrition & food research 52 (S1), S62-S70, 2008 | 149 | 2008 |
Epigenetic diagnostics of cancer—the application of DNA methylation markers J Paluszczak, W Baer-Dubowska Journal of applied genetics 47, 365-375, 2006 | 143 | 2006 |
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients A Majchrzak-Celińska, J Paluszczak, R Kleszcz, M Magiera, ... Journal of applied genetics 54, 335-344, 2013 | 84 | 2013 |
The activation of the Nrf2/ARE pathway in HepG2 hepatoma cells by phytochemicals and subsequent modulation of phase II and antioxidant enzyme expression V Krajka-Kuźniak, J Paluszczak, H Szaefer, W Baer-Dubowska Journal of Physiology and Biochemistry 71, 227-238, 2015 | 76 | 2015 |
Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa J Paluszczak, P Misiak, M Wierzbicka, A Woźniak, W Baer-Dubowska Oral oncology 47 (2), 104-107, 2011 | 75 | 2011 |
The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter … J Paluszczak, J Sarbak, M Kostrzewska-Poczekaj, K Kiwerska, ... Tumor Biology 36, 2855-2861, 2015 | 71 | 2015 |
Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro V Krajka-Kuźniak, J Paluszczak, W Baer-Dubowska Toxicology in Vitro 27 (1), 149-156, 2013 | 67 | 2013 |
Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells J Paluszczak, R Kleszcz, E Studzińska-Sroka, V Krajka-Kuźniak Molecular and Cellular Biochemistry 441, 109-124, 2018 | 60 | 2018 |
Targeting aberrant cancer metabolism–The role of sirtuins R Kleszcz, J Paluszczak, W Baer-Dubowska Pharmacological Reports 67 (6), 1068-1080, 2015 | 58 | 2015 |
Prognostic significance of the methylation of Wnt pathway antagonists—CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling—ZIC1, ZIC4, and HHIP in head and neck … J Paluszczak, D Wiśniewska, M Kostrzewska-Poczekaj, K Kiwerska, ... Clinical Oral Investigations 21, 1777-1788, 2017 | 45 | 2017 |
Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells R Kleszcz, A Szymańska, V Krajka-Kuźniak, W Baer-Dubowska, ... Cellular Oncology 42, 505-520, 2019 | 43 | 2019 |
The significance of the dysregulation of canonical Wnt signaling in head and neck squamous cell carcinomas J Paluszczak Cells 9 (3), 723, 2020 | 39 | 2020 |
Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas J Paluszczak, D Hemmerling, M Kostrzewska‐Poczekaj, ... Journal of oral pathology & medicine 43 (9), 652-657, 2014 | 29 | 2014 |
Phloretamide, an apple phenolic compound, activates the Nrf2/ARE pathway in human hepatocytes V Krajka-Kuźniak, J Paluszczak, L Celewicz, J Barciszewski, ... Food and Chemical Toxicology 51, 202-209, 2013 | 29 | 2013 |
Unknown face of known drugs–what else can we expect from angiotensin converting enzyme inhibitors? A Wzgarda, R Kleszcz, M Prokop, K Regulska, M Regulski, J Paluszczak, ... European journal of pharmacology 797, 9-19, 2017 | 28 | 2017 |
The methylation of a panel of genes differentiates low-grade from high-grade gliomas A Majchrzak-Celińska, J Paluszczak, M Szalata, AM Barciszewska, ... Tumor Biology 36, 3831-3841, 2015 | 28 | 2015 |
The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells R Kleszcz, J Paluszczak, V Krajka-Kuźniak, W Baer-Dubowska Advances in Clinical and Experimental Medicine 27 (6), 735-742, 2018 | 27 | 2018 |